Effects of continuous intake of test foods on bone - Effects of continuous intake of test foods on bone

Medical Corporation Hokubukai Utsukushigaoka Hospital0 sites40 target enrollmentJanuary 31, 2024

Overview

Phase: 未知
Intervention: Not specified
Conditions: Not specified
Sponsor: Medical Corporation Hokubukai Utsukushigaoka Hospital
Enrollment: 40
Status: Recruiting
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

January 31, 2024

End Date

July 7, 2023

Last Updated

2 years ago

Study Type

Interventional

Sex

Female

Investigators

Sponsor

Medical Corporation Hokubukai Utsukushigaoka Hospital

Eligibility Criteria

Inclusion Criteria

Not provided

Exclusion Criteria

•(1\) Subjects diagnosed with osteoporosis (2\) Subjects who suffer from the following chronic diseases and under medication: rheumatism, cerebrovascular disease, arrhythmia under treatment with warfarin, thyroid disease, adrenal gland disease (3\) Subjects with diabetes, hyperlipidemia or hypertension who are poorly controlled by medication (4\) Subjects with hepatic disorder (5\) Subjects with renal disorder (6\) Subjects with serious anemia (7\) Subjects who may cause allergic symptoms to the test food ingredients (polyphenols, gelatin, etc.) (8\) Subjects who may cause serious allergic symptoms due to ingestion of food or medicines (9\) Subjects who suffer from alcoholism or other mental disorder or have such a history (10\) Subjects who take supplements, foods for specified health uses, foods with functional claims, or foods with nutrient function claims that affect bone metabolism once or more per week, such as calcium, vitamin D, vitamin K, magnesium, isoflavones (including daidzein, genistein, equol, etc.) (11\) Subjects who plan to take foods with health claims or supplement foods newly during the study period (12\) Subjects who have received hormone replacement therapy within the past 6 months (13\) Subjects who have suffered a bone injury or illness such as a fracture within the past 6 months (14\) Subjects who have received treatment requiring hospitalization within the past 6 months (15\) Subjects who participated in other human clinical trials within the past 3 months, or those who plan to participate in other human clinical trials during the study period (16\) Subjects judged as unsuitable for the study by the investigator with other reasons